Invited Speakers

Invited Speakers

Meera-Agar-2

Professor Meera Agar

Professor of Palliative Medicine, IMPACCT Centre
University of Technology Sydney

Professor Meera Agar is Professor of Palliative Medicine, IMPACCT Centre (improving palliative, aged and chronic care through clinical research and translation), University of Technology Sydney. She is the Chair of Cancer Symptom Trials, the 14th Cancer Collaborative Trials Group. She is a practicing palliative medicine physician in South West Sydney, and her research interest is in clinical trials of symptom and supportive care interventions for people living with cancer.

Cai-Grau-1a

Professor Cai Grau

Professor, MD DMSc,
Department of Oncology and Danish Center for Particle Therapy (DCPT)
Aarhus University Hospital
Aarhus, Denmark

Cai Grau is Professor of Radiation Oncology at the Institute of Clinical Medicine at Aarhus University and heading the interdisciplinary radiotherapy research at the Department of Oncology and the Danish Center for Particle Therapy at Aarhus University Hospital in Aarhus, Denmark. He is chairman of the Scientific Committee of the Danish Comprehensive Cancer Center (DCCC.dk) and director of the national research center DCCC Radiotherapy (DCCCRT.dk). His main area of interest is research in head and neck oncology, high precision radiotherapy, proton therapy, and health economics in radiation oncology.

Professor Grau is active in several national and international research collaborative groups, including the Danish Head and Neck Cancer Group (DAHANCA), and is currently chairing the ESTRO task force on Health Economics in Radiation Oncology (HERO) and the European Particle Therapy Network (EPTN).

He has been the supervisor of 19 completed and 3 ongoing Ph.D. and DMSc studies within radiotherapy, particle therapy, medical physics, clinical oncology. He has published more than 200 scientific publications.

Georgia-Halkett

Associate Professor Georgia Halkett

Senior Research Fellow
School of Nursing, Midwifery and Paramedicine, Curtin University, WA

Associate Professor Georgia Halkett (PhD, FIR, BMedRad(Hons) Radiation Therapist, GAICD) is a Senior Research Fellow, in the School of Nursing, Midwifery and Paramedicine at Curtin University. Georgia currently holds a Cancer Council of WA Research Fellowship.  Associate Professor Halkett completed her PhD in December 2005 at the University of South Australia. Prior to completing her PhD she worked as a radiation therapist.  Associate Professor Halkett has been successful in attracting NHMRC, NBCF, Cancer Australia and Cancer Council Funding She is also a lead CI on an international project funded by the European Organisation of Research and Treatment of Cancer (EORTC). She has published more than 80 peer-reviewed articles and is currently supervising five PhD students.

Georgia’s program of research focuses on cancer patient’s psychosocial and information needs, communication between health professionals and cancer patients and research in radiation therapy. She is also conducting research addressing the needs of carers of patients diagnosed with terminal cancer.

Georgia recently led a multi-state Beyond Blue/Cancer Australia project which tested a radiation therapist led psycho-educational intervention designed to improve patient preparation for radiotherapy and reduce patient anxiety.

Gerry-Hanna

Associate Professor Gerry Hanna

Director of Radiation Oncology, Peter MacCallum Cancer Centre

Associate Professor Gerry Hanna is the Director of Radiation Oncology at the Peter MacCallum Cancer Centre, Melbourne and holds an honorary appointment with the University of Melbourne. A/Prof Hanna’s research interests are the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, technical radiotherapy, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy. He is chief investigator of the International Atomic Energy Agency’s “PERTAIN” study and previous co-chief Investigator of the CONCORDE study, a UK study of novel agents in combination with radiotherapy in the treatment of lung cancer. He is the Principle investigator on VCCC program examining how best to harness the synergy between radiotherapy and immunotherapy, and in particular CAR-T cell therapy. He is the Thoracic Sub-Study lead for the SARON study and a TMG member for the UK’s HALT and CONFIRM studies. He is a member of TROG and a member of the Australian National Particle therapy working group. Previously he was a Final Fellowship examiner for both the Royal College of Radiologists, London and the Faculty of Radiology of the Royal College of Surgeons in Ireland. He previously was a member of the UK’s Radiotherapy Board and Chair-Elect of the UK’s SABR Consortium. Away from work he enjoys cycling, good music and pretending to play the piano.

loius

Associate Professor Lois Holloway

Medical Physics Group Lead
Ingham Institute and Liverpool and Macarthur Cancer Therapy Centres

Lois Holloway leads the medical physics group at the Ingham Institute and Liverpool and Macarthur Cancer Therapy centres. She has a long interest in mathematical modelling for radiotherapy and is excited by ongoing developments and opportunities in both imaging and machine learning in this area. She leads the OzCAT (Computer Assisted Theragnostics) working to link distributed datasets to develop prognostic models for radiotherapy, particularly for situations where randomised clinical trial evidence is limited.

Professor Peter Hoskin

Consultant Clinical Oncologist
Mount Vernon Cancer Centre, Northwood, United Kingdom
Professor of Clinical Oncology, University of Manchester, United Kingdom

Peter Hoskin trained in clinical oncology at the Royal Marsden Hospital London and has been consultant in clinical oncology at Mount Vernon Cancer Centre, Northwood UK since 1992. He is also Professor in Clinical Oncology in the University of Manchester and Honorary consultant in clinical oncology at the Christie Hospital, Manchester and University College Hospital, London. Research interests focus on radiosensitisation, biomarkers, radiotherapy quality assurance, palliative radiotherapy, and brachytherapy. He is a member of the GEC ESTRO committee and ESTRO Board. In the UK chairs the Fellowship Examination Board for the Royal College of Radiologists and sits on the RCR Council. He has published extensively and was Editor of Clinical Oncology for 15 years. He is now Clinical Editor for Radiotherapy and Oncology and sits on several journal editorial boards.

Professor Paul Keall

NHMRC Senior Principal Research Fellow, University of Sydney

Paul Keall is a Professor in the Sydney Medical School, an NHMRC Senior Principal Research Fellow and the Director of the ACRF Image X Institute at the University of Sydney. His team of scientists, clinical partners and international collaborators create, share and apply novel cancer imaging and targeted radiotherapy methods. Several of these innovations have been translated to clinical practice for improved health care.

fionam2

Dr Fiona McDonald

Consultant Thoracic Clinical Oncologist
The Royal Marsden NHS Foundation Trust

Dr McDonald specialises in treating patients with lung cancers. She leads on technological developments to improve outcomes for patients, ensuring access to the forefront of radiotherapy technology. Dr McDonald’s research aims to develop individualised approaches to lung radiotherapy through the integration of novel imaging, targeted biological agents and immunotherapy with advanced radiotherapy techniques. She is on the steering committee for the British Thoracic Oncology Group and is the chair elect of the UK SABR Consortium. She is an active member of the European Organisation Research and Treatment of Cancer lung group and the International Association of the Study of Lung Cancer advanced radiotherapy committee.

850e5f2d72ca0d7a73cf342519d758a0

Professor Sabe Sabesan

Director, Department of Medical Oncology
Townsville Cancer Centre, Townsville Hospital and Health Services
Clinical Dean
College of Medicine and Dentistry, James Cook University

Professor Sabe Sabesan, BMBS, PhD, FRACP, is the Director of the Department of Medical Oncology at the Townsville Cancer Centre, Townsville Hospital and Health Services and the Clinical Dean, College of Medicine and Dentistry of the James Cook University. He has designed, implemented and published on various teleoncology models to enhance rural access to cancer services closer to home. In collaboration with Clinical Oncology Society of Australia (COSA), he led the development of the teleoncology guidelines and the Australasian Teletrial model. As the chair of the Queensland Health State-wide Teletrial Working Group and Co-chair of the Australian Teletrial Consortium of COSA, he has been leading the implementation of the teletrial model in Queensland and across Australia.

ASM Countdown

Important Dates

Abstract Submissions Open

16 September 2019

Registration Opens

9 October 2019

Peer Recognition Award Submissions Open

4 November 2019

Attendance Grant Applications Open

4 November 2019

Abstract Submissions Close

18 November 2019

Attendance Grant Applications Close

11 December 2019

Early Bird Registration Closes

24 January 2020

Abstract Presenter Registration Deadline

7 February 2020

 

Organising Committee
A/Prof Puma Sundaresan
Ms Jo Page
Ms Susan Goode
Ms Alisha Moore
Ms Renee Swanson
Mr Patrick Wheeler
Program Development Committee
A/Prof Puma Sundaresan
Ms Jo Page
Dr Paolo De Ieso
Ms Susan Goode
Ms Mel Grand
Dr Jane Ludbrook
Dr Lachlan McDowell
Ms Alisha Moore
Dr Lucinda Morris
Dr Sasha Senthi
Ms Renee Swanson